Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
All >

News > United Kingdom (GB)

Please find below news from the United Kingdom (Great Britain) as well as about organisations from this country.

Total search results: 2450 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2018-12-03
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
Sygnature Discovery Ltd.. (11/27/18). "Press Release: Sygnature Discovery Establishes US Office in Cambridge, MA". Nottingham & Cambridge, MA. 2018-11-27
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
Oxford BioMedica plc. (11/23/18). "Press Release: Oxford BioMedica Announces New Digital Framework Initiative to Streamline the Production of Next-generation Medicines with Cash Injection from Innovate UK". Oxford. 2018-11-23
GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London. 2018-11-22
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Immunocore Ltd.. (11/19/18). "Press Release: Immunocore to Co-develop IMC-C103C, a T Cell Redirecting Bi-specific Biologic, with Genentech". Oxford & Conshohocken, PA. 2018-11-19
Goodwin Procter LLC. (11/15/18). "Press Release: Goodwin Adds Life Sciences and Technology Partner Sophie McGrath in London". London. 2018-11-15
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
Cobra Biologics Ltd.. (10/30/18). "Press Release: Cobra Biologics and the University of Leeds Collaborate in BioProNET Funded Project". Keele & Leeds. 2018-10-30
Immunocore Ltd.. (10/26/18). "Press Release: Immunocore CEO Andrew Hotchkiss Appointed to the Board of the BIA". Oxford & Conshohocken, PA. 2018-10-26
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
NodThera Ltd.. (10/23/18). "Press Release: NodThera Announces the Appointment of Alison Strutt PhD as Head of Finance & Operations, the Launch of Its New Corporate Office in Boston and the Opening of Its Laboratory in Seattle". Cambridge, Boston, MA & Se 2018-10-23
Medicines Discovery Catapult, The. (10/22/18). "Press Release: Overcoming Bottlenecks in Early Drug Discovery with the Power of Sound. Medicines Discovery Catapult and AstraZeneca Collaborate to Unlock the Potential of Acoustic Mist Ionisation Mass Spect 2018-10-22
Randox Laboratories Ltd.. (10/16/18). "Press Release: Randox Collaboration with Centre for Personalised Medicine is Officially Launched". 2018-10-16
MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. 2018-10-16
Arcis Biotechnology Ltd.. (10/16/18). "Press Release: Arcis Biotechnology and Teleflex Sign License Agreement". Daresbury. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Randox Laboratories Ltd.. (10/12/18). "Press Release: Researching the Evidence Investigator". 2018-10-12
Roslin Cell Therapies (RoslinCT). (10/10/18). "Press Release: RoslinCT and Reprocell Awarded £1.2 Million Project from Innovate UK for Clinical-grade Stem Cell Production". Edinburgh & Glasgow. 2018-10-10
Owlstone Medical. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. 2018-10-10
Oxford Nanopore Technologies Ltd.. (10/10/18). "Press Release: MinIT Is Out – an Analysis and Device Control Accessory to Enable Powerful, Real-time DNA/RNA Sequencing by Anyone, Anywhere". 2018-10-10
Avacta Group plc. (10/10/18). "Press Release: Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs (NEB)". Edinburgh & Glasgow. 2018-10-10
MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. 2018-10-09
Arcis Biotechnology Ltd.. (10/2/18). "Press Release: Arcis Biotechnology Raises £1.25 Million (USD $1.63 Million) Funding and Opens further £0.5 Million Investment Opportunity through Capital Cell". Daresbury. 2018-10-02
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. 2018-10-01
Evonetix Ltd.. (10/1/18). "Press Release: Evonetix Partner with LioniX International to Enable DNA Synthesis at Scale". Cambridge & Enschede. 2018-10-01
Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London. 2018-10-01
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Clyde Biosciences Ltd.. (9/27/18). "Press Release: Major International FDA-led Study Confirms CellOptiq High Content Assay as Leading in vitro Platform to Assess Cardiotoxicity in New Drugs". Motherwell. 2018-09-27
Nightstar Therapeutics plc. (9/27/18). "Press Release: Nightstar Announces Pricing of Public Offering". Waltham, MA & London. 2018-09-27
TTP Labtech Ltd.. (9/27/18). "Press Release: Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies". Cambridge. 2018-09-27
Nightstar Therapeutics plc. (9/25/18). "Press Release: Nightstar Announces Proposed Public Offering of American Depositary Shares". Waltham, MA & London. 2018-09-25
NodThera Ltd.. (9/24/18). "Press Release: NodThera Announces the Appointment of Adam Keeney PhD as President and Chief Executive Officer". Cambridge & Boston, MA. 2018-09-24
Tissue Solutions Ltd.. (9/20/18). "Press Release: Tissue Solutions Ltd Expands Service Offering with HistologiX Ltd Acquisition". 2018-09-20
Addex Therapeutics S.A.. (9/20/18). "Press Release: Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as Part of the Tools for Human Drug and Brain Research (THuNDR2) Initiative from the Wellcome Trust". G 2018-09-20
Domainex Ltd.. (9/20/18). "Press Release: Domainex Appoints Dr Trevor Perrior as Chief Executive Officer". Cambridge. 2018-09-20
Oxford Genetics Ltd.. (9/20/18). "Press Release: Oxford Genetics Extends Its CRISPR Gene Editing Technology License Agreement from ERS Genomics to Support Its Growth Internationally". Oxford. 2018-09-20
Premaitha Health plc. (9/19/18). "Press Release: Legal Settlement and Licence Agreement with Illumina". Manchester. 2018-09-19
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
Virion Biotherapeutics Ltd.. (9/17/18). "Press Release: Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO". London. 2018-09-17
Horizon Discovery Group plc. (9/14/18). "Press Release: Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca as Part of Its Functional Genomics Discovery Platform". Cambridge. 2018-09-14
Novacyt S.A.. (9/13/18). "Press Release: Novacyt Partners with Applied Microarrays in Assay Design". Paris & Camberley. 2018-09-13
University of Oxford. (9/12/18). "Press Release: Novo Nordisk Research Centre Opens in Oxford". 2018-09-12
Arix Bioscience plc. (9/12/18). "Press Release: Arix Bioscience plc Announces Board Changes, Appointment of Arthur Pappas to the Board of Directors, David U’Prichard to Retire from Board". London. 2018-09-12
University of Glasgow. (9/11/18). "Press Release: Cutting-edge Electron Microscope Revealed at Opening of New £5m Structural Biology Centre". 2018-09-11
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. 2018-09-11
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Cell and Gene Therapy Catapult, The. (9/11/18). "Press Release: Stevenage Cell and Gene Therapy Catapult Centre Gets Green Light to Make New Cell and Gene Therapies". 2018-09-11
F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. 2018-09-10
Arecor Ltd.. (9/10/18). "Press Release: Arecor Secures £6m Investment for the Clinical Development of Its Diabetes Speciality Pharma Portfolio". Cambridge. 2018-09-10
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2018-09-05
Arix Bioscience plc. (9/4/18). "Press Release: Changes Announced to Executive Team to Accelerate Growth and Strategy". London. 2018-09-04
Azeria Therapeutics Ltd.. (9/4/18). "Press Release: Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital". Cambridge. 2018-09-04
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
Evox Therapeutics Ltd.. (9/3/18). "Press Release: Evox Therapeutics Completes £35.5 Million Series B Financing". Oxford. 2018-09-03
Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford. 2018-08-30
GlaxoSmithKline plc. (8/30/18). "Press Release: European Commission Approves Nucala (mepolizumab) for the Treatment of Children with Severe Asthma". London. 2018-08-30
Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford. 2018-08-30
BioAscent Discovery Ltd.. (8/29/18). "Press Release: BioAscent Appoints New Directors of Chemistry and Biosciences to Lead Integrated Drug Discovery Services". Newhouse. 2018-08-29
Orchard Therapeutics Ltd.. (8/29/18). "Press Release: Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources". Boston, MA & London. 2018-08-29
Kandy Therapeutics Ltd.. (8/29/18). "Press Release: Kandy Therapeutics Successfully Raises £25 Million in a Series C Financing". Stevenage. 2018-08-29
Congenica Ltd.. (8/28/18). "Press Release: Congenica Appoints Wendy Britten as Chief Financial Officer". Cambridge. 2018-08-28
British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". 2018-08-25
BRAIN AG. (8/22/18). "Press Release: BRAIN AG Announces the Creation of SolasCure Ltd. to Continue Development of Aurase". Zwingenberg. 2018-08-22
Immunocore Ltd.. (8/20/18). "Press Release: Immunocore Announces Start of Phase I ImmTAC Study in Patients with Solid Tumours". Oxford & Conshohocken, PA. 2018-08-20
Abzena plc. (8/16/18). "Press Release: Update on Partial Monetisation of Abzena Inside Portfolio". Cambridge. 2018-08-16
Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]". 2018-08-16
Adaptimmune Therapeutics plc. (8/15/18). "Press Release: Third Dosing Cohort to Be Initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort". Philadeliphia, PA & Oxford. 2018-08-15
Blueberry Therapeutics Ltd.. (8/14/18). "Press Release: Blueberry Therapeutics Limited Closes £10m Funding to Support Development of Nanomedicines Portfolio". Alderley Park. 2018-08-14
Orchard Therapeutics Ltd.. (8/13/18). "Press Release: Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline". Boston, MA & London. 2018-08-13
Artios Pharma Ltd.. (8/10/18). "Press Release: Artios Pharma Announces $84 million (£65 million) Series B Financing. Financing Round Led by New Investors Andera Partners and LSP". 2018-08-10
Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich. 2018-08-08
GlaxoSmithKline plc. (8/7/18). "Press Release: Iain Mackay Appointed GSK Chief Financial Officer". London. 2018-08-07
Bruker Corporation. (8/6/18). "Press Release: Bruker Announces Ultra-High Field NMR Orders from Major NMR Infrastructure Investment in the UK". Billerica, MA. 2018-08-06
Arix Bioscience plc. (8/6/18). "Press Release: Arix Bioscience Announces First VIPE Investment". London. 2018-08-06
Adaptimmune Therapeutics plc. (8/2/18). "Press Release: Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update". Philadeliphia, PA & Oxford. 2018-08-02
Phico Therapeutics Ltd.. (8/1/18). "Press Release: Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project". Cambridge. 2018-08-01
ReViral Ltd.. (8/1/18). "Press Release: ReViral Announces Series B Investment. ReViral Announces US$55 Million Series B Fundraising to Advance RSV Clinical Studies". London. 2018-08-01
Medicines Discovery Catapult, The. (7/30/18). "Press Release: Medicines Discovery Catapult Appoints New Chair as It Moves into the Next Phase of Delivery alongside UK Biotech and Academia". 2018-07-30
GlaxoSmithKline plc. (7/27/18). "Press Release: CHMP Recommend Nucala (mepolizumab) for the Treatment of Severe Eosinophilic Asthma Paediatric Patients in Europe". London. 2018-07-27
Healx Ltd.. (7/26/18). "Press Release: Healx Raises $10m as Investors Back AI to Find Rare Disease Treatments Faster". Cambridge. 2018-07-26
Peak Scientific Instruments Ltd.. (7/25/18). "Press Release: Peak Underlines Position as Leader in N2 Systems for Single Quad LC-MS with Genius SQ 24". 2018-07-25
GlaxoSmithKline plc. (7/25/18). "Press Release: GSK Delivers Improvements in Sales, Margins and Cash Flow in Q2 2018". London. 2018-07-25
GlaxoSmithKline plc. (7/25/18). "Press Release: GSK and 23andMe Sign Agreement to Leverage Genetic Insights for the Development of Novel Medicines". 2018-07-25
GlaxoSmithKline plc. (7/24/18). "Press Release: GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-Cell Therapy Programme to GSK". 2018-07-24
Endomagnetics Ltd. (Endomag). (7/23/18). "Press Release: Endomag Raises $10 Million USD (£8m GBP) to Establish a New Standard of Breast Cancer Care". Cambridge & London. 2018-07-23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

» top